Anti-Paxillin (phospho Y31) antibody [E228]
| Name | Anti-Paxillin (phospho Y31) antibody [E228] |
|---|---|
| Supplier | Abcam |
| Catalog | ab32115 |
| Prices | $391.00 |
| Sizes | 100 µl |
| Host | Rabbit |
| Clonality | Monoclonal |
| Isotype | IgG |
| Clone | E228 |
| Applications | WB ICC/IF ICC/IF IHC-P IP |
| Species Reactivities | Mouse, Rat, Human |
| Antigen | Synthetic phospho peptide corresponding to residues surrounding Tyr31 of human Paxillin |
| Blocking Peptide | Paxillin (phospho Y31) peptide |
| Description | Rabbit Monoclonal |
| Gene | PXN |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
![All lanes : Anti-Paxillin (phospho Y31) antibody [E228] (ab32115) at 1/10000 dilutionLane 1 : untreated NIH 3T3 cell lysateLane 2 : PDGF treated NIH 3T3 cell lysate](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_4/7866_WB%2520paxillin%2520phospho.jpg)
All lanes : Anti-Paxillin (phospho Y31) antibody [E228] (ab32115) at 1/10000 dilutionLane 1 : untreated NIH 3T3 cell lysateLane 2 : PDGF treated NIH 3T3 cell lysate
Immunofluorescent analysis of Paxillin (phospho Y31) expression in HeLa cell culture, using 1/250 ab32115.
Immunohistochemical analysis of Paxillin (phospho Y31) expression in paraffin-embedded human colon carcinoma using 1/100 ab32115.
Immunofluorescence analysis of HeLa cells, staining Paxillin (phospho Y31) with ab32115. Cells on the right were treated with MGAT1 shRNA. Cells were fixed with 2% paraformaldehyde, permeabilized using 0.2% Triton-X-100 and blocked by 5% BSA for 1 hour. Cells were incubated with primary antibody (1/400) overnight at 4°C. A FITC-conjugated donkey anti-rabbit IgG (1/500) was used as the secondary antibody.
Product References
Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast - Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast
Sausgruber N, Coissieux MM, Britschgi A, Wyckoff J, Aceto N, Leroy C, Stadler MB, Voshol H, Bonenfant D, Bentires-Alj M. Oncogene. 2015 Apr 23;34(17):2272-8.
Suppression of cancer progression by MGAT1 shRNA knockdown. - Suppression of cancer progression by MGAT1 shRNA knockdown.
Beheshti Zavareh R, Sukhai MA, Hurren R, Gronda M, Wang X, Simpson CD, Maclean N, Zih F, Ketela T, Swallow CJ, Moffat J, Rose DR, Schachter H, Schimmer AD, Dennis JW. PLoS One. 2012;7(9):e43721.
Paxillin and hydrogen peroxide-inducible clone 5 expression and distribution in - Paxillin and hydrogen peroxide-inducible clone 5 expression and distribution in
Caltagarone J, Hamilton RL, Murdoch G, Jing Z, DeFranco DB, Bowser R. J Neuropathol Exp Neurol. 2010 Apr;69(4):356-71. doi:
PRL-3 down-regulates PTEN expression and signals through PI3K to promote - PRL-3 down-regulates PTEN expression and signals through PI3K to promote
Wang H, Quah SY, Dong JM, Manser E, Tang JP, Zeng Q. Cancer Res. 2007 Apr 1;67(7):2922-6.